Medical News, Journals & Upcoming Events

RSS Most Read Psychiatry Articles on JAMA Network
RSS JAMA Oncology Current Issue
  • JAMA Oncology Peer Reviewers in 2023 May 16, 2024
    We sincerely thank the 878 peer reviewers who completed manuscript reviews for JAMA Oncology in 2023.
  • Hypofractionated vs Conventional Postprostatectomy Radiotherapy for GI and GU Symptoms May 1, 2024
    This randomized clinical trial aims to determine if hypofractionated postprostatectomy radiotherapy is noninferior to conventionally fractionated postprostatectomy for patient-reported genitourinary (GU) and gastrointestinal (GI) symptoms at 2 years.
  • Quantification of Treatment Effect of Tislelizumab vs Sorafenib for Hepatocellular Carcinoma May 1, 2024
    To the Editor Qin and colleagues conducted an important trial to compare tislelizumab with sorafenib. The study was designed within a noninferiority setting for overall survival (OS) by claiming tislelizumab would be noninferior to sorafenib if the upper bound of the 95.003% CI for the hazard ratio (HR) was less than 1.08. The observed HR […]
  • Hypofractionation for Postprostatectomy Radiotherapy May 1, 2024
    Hypofractionation for prostate radiotherapy is well established, with international guidelines supporting the use of moderately hypofractionated radiotherapy for patients who choose external beam radiotherapy for treatment of prostate cancer. Hypofractionated radiotherapy enables better convenience for patients and cost benefits and, in comparison with conventional fractionation, has similar cancer-related outcomes and late gastrointestinal (GI) and genitourinary […]

RMEI CE Featured Activities